• Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
  • Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
  • Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
  • Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
  • Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
  • Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2

Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Solid
Purity: >99%
Samples:
US$ 330/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
Diclazuril
Appearance
White Powder
CAS No.
101831-37-2
Application
Pharmaceuticals
Function
Antiparasitic
Transport Package
Aluminium Foil Bag, Cardboard Drum
Specification
99%
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
5000kg/Month

Product Description

Human API Antiparasitic drug Antiprotozoal Diclazuril Powder CAS No.101831-37-2
Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
Product Name
  Diclazuril
Specification
Pure
Lead time
Usually about 5-7 days
Shipment
DHL, FedEx, EMS, TNT, By Air or By sea if large quantity
Payment
Alibaba Trade Assurance, Western Union, TT, Accept Euros
Package
1kg by cartons, 25kg by drums, or as customers' request
Quality
Guaranteed, Support refund fully if poor quality
NOTE
The info on web just for reference showing, Pls contact Marshall and ask for more details, including price & COA and so on.

Diclazuril is an anti-coccidial drug. Target: AntiparasiticDiclazuril is a coccidiostat, the lambs treated with diclazuril showed an intense, persistent oocyst excretion, with average levels of 97.54 opg, considerably higher than those recorded in the animals treated with toltrazuril (p < 0.05). Diclazuril is effective against E. maxima later in its life cycle, subclinical intestinal lesions may be present for a short time after infection. Diclazuril was shown in studies to reduce lesion scores and improve performance and health of birds challenged with E. maxima.
Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2Human API Antiparasitic Drug Antiprotozoal Diclazuril Powder CAS No. 101831-37-2
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now